Collplant appoints collagen biomaterials expert as new head of north america commercial operations

New u.s.-based role to support growth strategy, partnerships, and scaling of rhcollagen product platforms rehovot, israel , july 14, 2025 /prnewswire/ -- collplant biotechnologies (nasdaq: clgn), a regenerative and aesthetics medicine company developing disruptive technologies and products based on its non-animal-derived recombinant human collagen (rhcollagen), today announced the appointment of bowman bagley as vice president, commercial north america. in this newly created role, mr.
CLGN Ratings Summary
CLGN Quant Ranking